Back to calendar
ARS Pharmaceuticals, Inc. (SPRY) Earnings
SPRY reports earnings on Wednesday, August 12, 2026
earnings report
August 12, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.48
Actual EPS: $-0.61
EPS surprise: -18.22%
Company overview
Market Cap$755.7M
PriceUSD 7.61
EPS (TTM)-2.00
52-week high18.63
52-week low6.66
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees163